UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000001050
Receipt number R000001258
Scientific Title A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
Date of disclosure of the study information 2008/03/01
Last modified on 2015/08/27 16:13:13

No. Disposal Last modified on Item of update
1 Insert 2008/02/24 20:05:16
2 Update 2011/03/06 15:08:51 Name of person sending information
Organization
Division name
Address
3 Update 2011/08/26 17:45:57 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2011/08/26 17:46:48 Recruitment status
5 Update 2012/02/27 15:22:26 Last follow-up date
6 Update 2013/09/07 18:55:44 Email
7 Update 2014/02/24 11:43:03 Recruitment status
8 Update 2015/08/27 16:13:13 Recruitment status
Last follow-up date